AI-generated summary
The authors report a 24-week randomized, double-blind, sham device-controlled trial of 80 people with androgenetic alopecia, testing combined photobiomodulation and pulsed electromagnetic field therapy. Hair density rose more in the treatment group than in the control group, a difference the authors describe as statistically significant, and only very mild erythema or irritation was reported.
- Participants
- 80
- Who or what was studied
- Adults with androgenetic alopecia
- Limits stated in the abstract
- The abstract does not report the size of each group, long-term follow-up beyond 24 weeks, or how the global assessment by independent experts was scored.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Photobiomodulation therapy (PBMT) appears to be safe and effective for hair loss. Pulsed electromagnetic field therapy (PEMF) also has a positive biological effect on hair re-growth.
Objectives
We evaluated the efficacy and safety of both PBMT and PEMF for the treatment of androgenetic alopecia (AGA).
Materials And Methods
This study was a 24-week, randomized, double-blind, sham device-controlled trial. We recruited 80 subjects with androgenetic alopecia. The subjects got treatment every week for the 1st 12 weeks, every other week for the next 8 weeks. PBMT entails 15-min therapy, and PEMF was carried out for 10 min.
Results
The baseline hair density was 114.57 (±28.75)/cm2 and 113.31 (±30.07)/cm2 in both treatment and control groups. After 24 weeks of treatment, the mean hair density increased to 139.37 (±31.4)/cm2 in the treatment group but only to 119.78 (±31.92)/cm2 in the control group. The difference between two groups was statistically significant (p < 0.05). Based on the global assessment of independent experts, the score was 0.41 (±0.62) in the treatment group and 0.07 (±0.45) in the control group. Only very mild erythema or irritation was reported, and no serious adverse reactions were reported.
Conclusions
A combination of PBMT and PEMF is a valid and safe treatment option for AGA.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Androgenetic alopecia, Photobiomodulation, Control group, Sham device, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.